[Ruxolitinib combined with venetoclax and azacitidine in the treatment of refractory T-ALL patients with JAK1, JAK3, and STAT5B gene mutations: a case report and literature review].
Peipei Xu(Nanjing Drum Tower Hospital), B Chen(Nanjing Drum Tower Hospital), Jian Ouyang(Nanjing Drum Tower Hospital), Tong Zhou(Xiamen University), Y Y Xu(Nanjing Drum Tower Hospital), Miao Peng(Central South University), Ting Xie(Sun Yat-sen University), Yang Du(State Key Laboratory of Gas Disaster Detecting, Preventing and Emergency Controlling), Yihua Yang(Nanjing Drum Tower Hospital)
Cited by 1
Related Papers
STEM CELL NICHE: Structure and Function
|Annual Review of Cell and Developmental Biology|2005|1.2k
decapentaplegic Is Essential for the Maintenance and Division of Germline Stem Cells in the Drosophila Ovary
|Cell|1998|685